Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Surgical Site Infection: later-stage trial registry
9 of 26 indexed Surgical Site Infection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #627 of 28,707 conditions by registered trial count.
26 US clinical trials · 9 currently recruiting · #627 of 28,707 conditions by registered trial count
Surgical Site Infection: 26 US clinical trials tracked, 9 recruiting.
Surgical Site Infection is the subject of 26 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 11 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Durata Therapeutics Inc., an affiliate of Allergan, running 1 of these trials.
Enrollment posture brief
Registry condition surgical-site-infection
OPEN 9 | RECR 35% | LATE 11 | EARLY 4 | RANK #627 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Cervical Carcinoma (35% recruiting · 26 trials)
Surgical Site Infection lists 9 open slots (35% of 26 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Surgical Site Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Surgical Site Infection is recruiting below its size-band peers.
9 of 26 indexed trials (34.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Surgical Site Infection trials is spread across many organizations.
Durata Therapeutics Inc., an affiliate of Allergan accounts for 1 of 26 trials (3.8%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Surgical Site Infection enrolment sits around 298 participants.
Median target enrolment is 298 among the 26 trials that report a genuine target (sentinel values excluded). 8 of those (30.8%) plan for fewer than 100 participants.
-
Surgical Site Infection research is mostly interventional.
24 interventional and 2 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
26 total, page 1 of 1
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
University of California, Irvine
NCT05586776
Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery
Carilion Clinic
NCT04580472
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
Loma Linda University
NCT06363877
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
University of North Carolina, Chapel Hill
NCT06649890
Irrisept Solution for Instrumented Spine Surgery
Rhode Island Hospital
NCT06439953
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
Sean Devitt
NCT04725916
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
University of Nevada, Las Vegas
NCT06309368
Zinc Oxide Versus Petrolatum Following Skin Surgery
Melissa Pugliano-Mauro
NCT03561376
Reducing Wound Infections Using Bioelectric Wound Dressings
AdventHealth
NCT06312267
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
Loreen Herwaldt
NCT05763602
Tobramycin Injection to Prevent Infection in Open Fractures
Massachusetts General Hospital
NCT04964947
One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection
OrthoCarolina Research Institute
NCT02734134
Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients
Boston Children's Hospital
NCT04773457
Effect of Preoperative Diet on Perioperative Gut Microbiome
Stanford University
NCT05027763
Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures
University of Maryland, Baltimore
NCT03385304
Reducing Perioperative S. Aureus Transmission Via OR PathTrac
Georgetown University
NCT04657185
Multicenter Infection Surveillance Study Following Open Heart Surgery
Halyard Health
NCT00673712
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Durata Therapeutics Inc., an affiliate of Allergan
NCT01339091
Topical Antibiotic Prophylaxis for Eyelids
University of California, San Francisco
NCT03199911
Air Barrier System for the Prevention of Surgical Site Infection
Nimbic Systems
NCT01610271
Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal Surgery
The Cleveland Clinic
NCT02509260
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
Destiny Pharma
NCT03915470
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
St. Louis University
NCT05919888
The Effect of Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery
James A. Haley Veterans Administration Hospital
NCT01831154
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
Zurex Pharma
NCT02296645
Topical Treatment and Prevalence of P. Acnes
University of Southern California
NCT03257202
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 3 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Surgical Site Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Surgical Site Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Surgical Site Infection page
26 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Surgical Site Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Durata Therapeutics Inc., an affiliate of Allergan sponsors the most Surgical Site Infection trials on record, review their full trial history before evaluating a specific study. See Durata Therapeutics Inc., an affiliate of Allergan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Surgical Site Infection condition card totals 26 registered trials; most-linked intervention Povidone-Iodine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.